Misicka A, Lipkowski A W, Slaninova J, Davis P, Yamamura H I, Porreca F, Hruby V J
Department of Chemistry, University of Arizona, Tucson 85721, USA.
Life Sci. 1995;57(18):1633-40. doi: 10.1016/0024-3205(95)02142-6.
Analysis of possible mu opioid receptor active conformations for dermorphin suggested that the topographical location of the tyramine moiety of the N-terminal tyrosine can be simulated with the phenol of tyrosine or desamino-tyrosine (4-hydroxyphenylpropionic acid) and a basic group located on the side chain of a dibasic acid residue located in position 2. The biological properties of respective analogs with D- or L-arginine, and D- or L-lysine in the position 2 of dermorphin or desamino-dermorphin and their N-terminal tetrapeptide fragments, has provided evidence in support of this prediction, and questions the dogma that an N-terminal tyrosine is a necessary element for opioid agonist peptides.